VR Logo

Bone Biologics Corp (BBLG) download report


Healthcare | Medical Devices & Equipment

Bone Biologics Corp (BBLG) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.

IPO Date: 31-Mar-2016

Pres & CEO: Mr. Jeffrey Frelick

Chief Financial Officer: Ms. Deina H. Walsh

Listing: NASDAQ: BBLG

Country: United States

Headquarters: Burlington, MA

Website: https://www.bonebiologics.com

Key Facts

Market cap: $13.25 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-1.87 Mln

Cash: $5.81 Mln

Total Debt: $0.00 Mln

Insider's Holding: 69.61%

Liquidity: Low

52 Week range: $1.13 - 7.12

Shares outstanding: 10,350,600

8 Years Aggregate:

  • CFO: $-25.97 Mln
  • EBITDA: $-9.38 Mln
  • Net Profit: $-57.67 Mln

Stock Performance

Time Period Bone Biologics (BBLG) S&P BSE Sensex* S&P Small-Cap 600*
YTD-63.64-8.62-18.78
1 month-21.47-4.54-8.00
3 months-53.96-10.19-13.65
1 Year--1.43-17.19
3 Years--10.146.10
5 Years-58.1311.265.87
10 Years--11.829.84
As on 01-Jul-2022 *As on 04-Jul-2022
Year Bone Biologics (BBLG) S&P Small-Cap 600 S&P BSE Sensex
2017-43.3111.7327.91